Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Medtronic lands CE Mark approval in the European Union for its new Engager transcatheter aortic valve implantation system.
Boston Scientific’s Watchman heart implant scored better on quality-of-life measures than the anti-clotting drug warfarin after 1 year, according to a report in the Journal of the American College of Cardiology.
The Healthcare Supply Chain Assn. names 45 medical device companies it says are shifting the cost of the 2.3% federal excise tax, among them Allergan and Invacare.